Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (33)

2023

  1. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial

    Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167

2022

  1. No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group

    Disease markers, Vol. 2022, pp. 3132941

2021

  1. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

    Leukemia, Vol. 35, Núm. 8, pp. 2358-2370

  2. OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors

    Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472

2019

  1. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

2015

  1. Febrile young infants with altered urinalysis at low risk for invasive bacterial infection. A Spanish pediatric emergency research network's study

    Pediatric Infectious Disease Journal, Vol. 34, Núm. 1, pp. 17-21

2012

  1. Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis

    Revista de Neurologia, Vol. 54, Núm. 2, pp. 114-124

2009

  1. Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia

    European Journal of Cancer, Vol. 45, Núm. 10, pp. 1877-1889

  2. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

    Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453

  3. Hacia un programa de Garantía Externa de Calidad para Laboratorios de Inmunología Diagnóstica asociado a la Sociedad Española de Inmunología (GECLID-SEI)

    Inmunologia

  4. MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

    Molecular Cancer, Vol. 8, pp. 69

  5. Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis

    Journal of Molecular Diagnostics, Vol. 11, Núm. 5, pp. 458-463

2008

  1. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia

    British Journal of Haematology, Vol. 142, Núm. 4, pp. 571-582

  2. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth

    Molecular Cancer Research, Vol. 6, Núm. 12, pp. 1830-1840

  3. Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia

    Cancer Science, Vol. 99, Núm. 9, pp. 1865-1868

  4. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia

    Leukemia Research, Vol. 32, Núm. 3, pp. 487-490

  5. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

    Leukemia Research, Vol. 32, Núm. 5, pp. 709-716

2007

  1. Epigenetic regulation of PRAME gene in chronic myeloid leukemia

    Leukemia Research, Vol. 31, Núm. 11, pp. 1521-1528

  2. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

    Blood, Vol. 109, Núm. 8, pp. 3462-3469

  3. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia

    Haematologica, Vol. 92, Núm. 2